Assessing the Impact of Digitalization on Women Entrepreneurs in India: Strategies and Challenges
ISDA JOURNAL · 2026
DOI: 10.26634/isda.36.3.11316 ↗Kurz gefasst
Fachartikel in der Zeitschrift ISDA JOURNAL, 2026. Verfasst von Shaliya Dinsha. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
The digital revolution presents significant opportunities for women entrepreneurs, offering accessible and scalable platforms for business growth. As affordable smartphones and internet access become widespread, women increasingly utilize digital tools to launch and manage businesses. This study adopts a qualitative approach to investigate the impact of digitalization on female entrepreneurs by examining five key factors: operational efficiency, costs, accessibility, customer satisfaction, and innovation through effective digital strategies. Additionally, the study explores the obstacles women entrepreneurs face in the digital landscape. A case study approach, involving semi-structured interviews with seven women entrepreneurs, was used, and data were analysed using NVivo 14 software. Findings reveal that digital platforms provide flexibility, expand customer reach, and enhance product delivery. Digital payment systems and business networks improve efficiency and foster social capital. However, challenges like cyberbullying, misuse of content, and cybersecurity risks remain, requiring stronger policies, better cybersecurity, and digital training.
Zitieren
APA
Dinsha, S. (2026). Assessing the Impact of Digitalization on Women Entrepreneurs in India: Strategies and Challenges. ISDA JOURNAL. https://doi.org/10.26634/isda.36.3.11316
Vancouver
Dinsha S. Assessing the Impact of Digitalization on Women Entrepreneurs in India: Strategies and Challenges. ISDA JOURNAL. 2026. doi:10.26634/isda.36.3.11316
BibTeX
@article{Dinsha2026,
author = {Dinsha, Shaliya},
title = {Assessing the Impact of Digitalization on Women Entrepreneurs in India: Strategies and Challenges},
journal = {ISDA JOURNAL},
year = {2026},
doi = {10.26634/isda.36.3.11316}
}
EUVIMED